Company

Sagitta Biotech

Biotechnology Liège Walloon Region, Be 4 employees

Employees: 4
Contacts: 1
Emails: 1

www.sagittabiotech.com LinkedIn

Sagitta Biotech Overview

Headquarters: Liège Walloon Region, Be
Website: www.sagittabiotech.com
Industry: Biotechnology
Employees: 4
Founded: 2019

Keywords

immunotherapy cancer oncolytic virus checkpoint inhibitors vaccines multivalent vaccines gene therapy

About Sagitta Biotech

Sagitta Biotech is a company developping an innovative viral vector to develop efficient vaccines, oncolytic viruses and gene therapy vectors. Our active virosome platform can deliver up to 17kb mRNA (6 genes), and elicit both humoral and cellular reponse. Sagitta is developping its own pipeline of innovative multivalent vaccines (currently in preclinical phases) and oncolytic viruses, and is open to partnering and co-development. In ancient Greece, Sagitta was regarded as the weapon that Hercules used to kill the eagle (Aquila) of Jove that perpetually gnawed Prometheus' liver.

Sagitta Biotech Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Sagitta Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ywenn Samyn	Msc in Biomedical Sciences, Liege University		View
Philippe Monteyne	Partner at Aliath Bioventures (Altamarcam Partners)		View
Houda Gouasmia	Scientist and Lab Manager - Sagitta Biotech	Liège, Walloon Region, Belgium	Email